upon condensation with histamine. Histamine Blue displays
very good selectivity over a broad range of signalling molecules
and metabolites due to the catalytic effect of the imidazole group,
and is the first fluorescent small molecule for imaging histamine
in live RBL-2H3 basophils. Histamine Blue can also monitor the
uptake and de novo synthesis of histamine in live RAW 264.7
macrophages and its fluorescence intensity correlates well with
the histamine levels in cell extracts. This discovery may assist the
investigation of the roles that histamine plays in mammalian
physiology and a number of pathologies.
The authors acknowledge the financial support from DGICYT
(CTQ 2009-07758), the Generalitat de Catalunya (2009/
SGR/208), Barcelona Science Park, Grupo Ferrer (Barcelona,
Spain) and the intramural funding and grant 10/1/21/19/656
from A*STAR (Singapore). N. K. thanks DGICYT for a PhD
fellowship.
Notes and references
1 M. A. Beaven, N. Engl. J. Med., 1976, 294, 30.
2 A. Lundequist and G. Pejler, Cell. Mol. Life Sci., 2011, 68, 965.
3 C. F. Code, Fed. Proc., 1965, 24, 1311.
4 F. Andras and K. Meretey, Immunol. Today, 1992, 13, 154.
5 M. B. Passani and P. Blandina, Trends Pharmacol. Sci., 2011,
32, 242.
6 Y. Makabe-Kobayashi, Y. Hori, T. Adachi, S. Ishigaki-Suzuki,
Y. Kikuchi, Y. Kagaya, K. Shirato, A. Nagy, A. Ujike, T. Takai,
T. Watanabe and H. Ohtsu, J. Allergy Clin. Immunol., 2002,
110, 298.
7 E. O. Alvarez, Behav. Brain Res., 2009, 199, 183.
8 R. Hakanson, A. L. Ronnberg and K. Sjolund, Anal. Biochem.,
1972, 47, 356.
9 C. N. Jayarajah, A. M. Skelley, A. D. Fortner and R. A. Mathies,
Anal. Chem., 2007, 79, 8162.
10 T. Yoshitake, M. Yamaguchi, H. Nohta, F. Ichinose, H. Yoshida,
S. Yoshitake, K. Fuxe and J. Kehr, J. Neurosci. Methods, 2003,
127, 11.
Fig. 4 RAW 264.7 macrophages after treatment with Histamine Blue.
Bright field (upper) and fluorescent (lower) images after incubation with
Histamine Blue of: (a) RAW 264.7, (b) RAW 264.7 after histamine
uptake and (c) RAW 264.7 after treatment with thapsigargin. Scale bar:
20 mm. (d) Average fluorescence intensities of cells stained with
Histamine Blue (black) and quantification of histamine levels per 106
cells (grey) in RAW 264.7 before and after chemical treatment and in
RBL-2H3 basophils.
11 F. R. Antoine, C. Wei, W. S. Otwell, C. A. Sims, R. C. Littell,
A. D. Hogle and M. R. Marshall, J. Agric. Food Chem., 2002,
50, 4754.
12 T. Lim, H. Ohta and T. Matsunaga, Anal. Chem., 2003, 75, 3316.
13 J. Hu, T. Chen, M. Li, G. He, J. Meng, X. Ma, Y. Wu, M. Jia and
X. Luo, Neurosci. Res., 2007, 59, 231.
14 D. Seto, N. Soh, K. Nakano and T. Imato, Anal. Biochem., 2010,
404, 135.
15 D. Seto, N. Soh, K. Nakano and T. Imato, Bioorg. Med. Chem.
Lett., 2010, 20, 6708.
´
16 J. Zhu and H. Bienayme, Multicomponent reactions, WILEY-VCH,
histamine under normal conditions. Histamine Blue did not
stain non-treated macrophages (Fig. 4a), while brightly
stained them after the uptake of histamine (Fig. 4b). Titration
experiments showed that Histamine Blue stained RAW
264.7 cells in a histamine uptake-dependent manner (Fig. S8
in ESIw). These results are consistent with previous reports
indicating that RAW 264.7 macrophages can reach histamine
levels similar to basophils after incubation with 10 mM
histamine for 2 h.24 Furthermore, we determined the amount
of histamine in extracts of RBL-2H3 basophils and RAW
264.7 macrophages by the conventional method using
o-phthaldialdehyde.25 In vitro quantification of the histamine
levels correlated well with the fluorescence intensity of
Histamine Blue in live cell imaging (Fig. 4d). Finally we
induced de novo synthesis of histamine in RAW 264.7 by
treatment with thapsigargin, an endomembrane Ca2+-ATPase
inhibitor.26 Histamine Blue stained thapsigargin-treated
macrophages (Fig. 4c) more brightly than non-treated macrophages
(Fig. 4a). Altogether we proved that Histamine Blue can be
used for imaging histamine in live basophils and macrophages
under different physiological conditions.
Weinheim, 2005.
17 N. Isambert and R. Lavilla, Chem.–Eur. J., 2008, 14, 8444.
18 J. S. Lee, H. K. Kim, S. Feng, M. Vendrell and Y. T. Chang, Chem.
Commun., 2011, 47, 2339.
´
19 M. J. Arevalo, N. Kielland, C. Masdeu, M. Miguel, N. Isambert
and R. Lavilla, Eur. J. Org. Chem., 2009, 617.
20 D. W. Knight, e-EROS Encyclopedia of Reagents for Organic
Synthesis, John Wiley & Sons, Ltd., Chichester, 2001, pp. 194–195.
21 M. Suchy, A. A. H. Elmehriki and R. H. E. Hudson, Org. Lett.,
2011, 13, 3952.
22 K. Nakatani, M. Atsumi, T. Arakawa, K. Oosawa, S. Shimura,
N. Nakahata and Y. Ohizumi, Biol. Pharm. Bull., 2002, 25, 1137.
23 E. Passante and N. Frankish, Inflammation Res., 2009, 58, 737.
24 S. Tanaka, K. Deai, M. Inagaki and A. Ichikawa, Am. J. Physiol.
Cell. Physiol., 2003, 285, 592.
25 P. A. Shore, A. Burkhalter and V. Cohn, J. Pharmacol. Exp. Ther.,
1959, 127, 182.
26 M. Shiraishi, N. Hirasawa, Y. Kobayashi, S. Oikawa,
A. Murakami and K. Ohuchi, Br. J. Pharmacol., 2000, 129, 515.
In summary, we developed a new fluorescent probe (Histamine
Blue) for imaging histamine in live cells. Histamine Blue is a
mesoionic acid fluoride showing a 14-fold fluorescence increase
c
This journal is The Royal Society of Chemistry 2012
Chem. Commun., 2012, 48, 7401–7403 7403